Cargando…
Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy
Autores principales: | Abbott, J, Pineiro, R, Oliviero, MA, Lattanzio, R, Piantelli, M, Bilancio, A, Maffucci, T, Falasca, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875572/ http://dx.doi.org/10.1186/bcr2507 |
Ejemplares similares
-
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
por: Chikh, Anissa, et al.
Publicado: (2016) -
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
por: Tibolla, Gianpaolo, et al.
Publicado: (2013) -
Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
por: Maffucci, Tania, et al.
Publicado: (2005) -
Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion
por: Mavrommati, Ioanna, et al.
Publicado: (2016) -
Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling
por: Maffucci, Tania, et al.
Publicado: (2020)